Saturday, May 21, 2016

UPDATE 1-Struggling Novartis heart drug boosted by new medical guidelines

* Amgen's Corlanor also added to guideline list

(Adds comment from Novartis and analyst)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)